Stocks and Investing Stocks and Investing
Wed, August 7, 2024
Tue, August 6, 2024

Joseph Pantginis Maintained (ATNM) at Strong Buy with Decreased Target to $4 on, Aug 6th, 2024


Published on 2024-10-28 13:16:06 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy with Decreased Target from $50 to $4 on, Aug 6th, 2024.

Joseph has made no other calls on ATNM in the last 4 months.



There are 2 other peers that have a rating on ATNM. Out of the 2 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Sudan Loganathan of "Stephens & Co." Initiated at Buy and Held Target at $25 on, Tuesday, May 14th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $21 on, Tuesday, April 30th, 2024

Contributing Sources